Kinases and phosphatases in ischaemic preconditioning: a re-evaluation

Basic Research in Cardiology
W J FanAmanda Lochner

Abstract

Activation of several protein kinases occurs during myocardial ischaemia and during subsequent reperfusion. In contrast to the intensive investigation into the significance of kinase activation in cardioprotection, relatively little is known about the role of the phosphatases in this regard. The aim of this study was to re-evaluate the putative roles of PP1 and PP2A in ischaemia/reperfusion and in triggering ischaemic preconditioning. Isolated perfused working rat hearts were subjected to sustained global (15 or 20 min) or regional ischaemia (35 min), followed by reperfusion. Hearts were preconditioned using global ischaemia (1 x 5 or 3 x 5 min, alternated with 5 min reperfusion). To inhibit both PP1 and PP2A cantharidin (5 muM) was used. To inhibit PP2A only, okadaic acid (7.5 nM) was used. The drugs were administered during the preconditioning protocol, before onset of sustained ischaemia (pretreatment) or during reperfusion. Endpoints were mechanical recovery during reperfusion, infarct size and activation of PKB/Akt, p38 MAPK and ERK p42/p44, as determined by Western blot. Pretreatment of hearts with okadaic acid or cantharidin caused a significant reduction in mechanical recovery after 15 or 20 min global ischaemia. Admini...Continue Reading

References

Feb 1, 1979·Journal of Molecular and Cellular Cardiology·G J KannengiesserT J van der Werff
Mar 31, 1989·Biochemical and Biophysical Research Communications·H IshiharaD Uemura
Jul 1, 1994·Pflügers Archiv : European journal of physiology·C LuR W Joyner
Aug 1, 1995·Journal of Molecular and Cellular Cardiology·D P JenkinsD M Yellon
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·M AndjelkovićB A Hemmings
Jan 22, 1998·The Annals of Thoracic Surgery·B FarisP Menasché
Mar 17, 1998·Journal of Molecular and Cellular Cardiology·S C ArmstrongC E Ganote
Jul 1, 1998·Progress in Cardiovascular Diseases·K Przyklenk, R A Kloner
Nov 13, 1998·Science·M H CardoneJ C Reed
Aug 13, 1999·Journal of Cardiovascular Pharmacology·M BarancikW Schaper
Nov 13, 1999·Nature Cell Biology·J Downward
Mar 31, 2000·Experimental Cell Research·T G CrossJ M Lord
Jul 20, 2000·Journal of Molecular and Cellular Cardiology·K Mackay, D Mochly-Rosen
Jun 1, 2002·Circulation Research·Stefan E Hardt, Junichi Sadoshima
Aug 16, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Yury LadilovH Michael Piper
Mar 22, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Qinghang Liu, Polly A Hofmann
Sep 5, 2003·Basic Research in Cardiology·A LochnerJ A Moolman
Mar 3, 2004·The Journal of Pharmacology and Experimental Therapeutics·David A LiemDirk J Duncker
Apr 10, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Derek J HausenloyMichael R Duchen
Jun 18, 2004·Annals of the New York Academy of Sciences·Michael V G LatronicoGianluigi Condorelli
Sep 11, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Derek J HausenloyDerek M Yellon
May 12, 2005·Trends in Cardiovascular Medicine·Derek J HausenloyDerek M Yellon

❮ Previous
Next ❯

Citations

Mar 15, 2011·Basic Research in Cardiology·Xiulan YangJames M Downey
Oct 21, 2015·Frontiers in Neuroscience·Ludmila D Lukyanova, Yulia I Kirova
May 31, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Yan WuQingping Feng
Dec 14, 2011·Journal of Molecular and Cellular Cardiology·Feng Hua Yang, W Glen Pyle
Aug 31, 2010·Journal of Molecular and Cellular Cardiology·Rui SiFeng Gao
Feb 6, 2018·Heart Failure Reviews·Fallou WadeCoralie Poizat
Nov 22, 2017·Journal of Cellular and Molecular Medicine·Xavier RosselloDerek M Yellon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.